MiR-770 Suppresses the Chemo-resistance and Metastasis of Triple Negative Breast Cancer Via Direct Targeting of STMN1

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2018 Jan 12

PMID 29323124

Citations 79

Authors

Yaming Li

Yiran Liang

Yuting Sang

Xiaojin Song

Hanwen Zhang

Ying Liu

Liyu Jiang

Qifeng Yang

Affiliations

Soon will be listed here.

Abstract

Chemo-resistance and metastasis of triple negative breast cancer (TNBC) contributed the most of treatment failure in the clinic. MicroRNAs (miRNAs) have been proved to be involved in many biological processes and diseases. In this study, we aimed to determine the role of miR-770 in the regulation of chemo-resistance and metastasis of TNBC. Clinically, miR-770 was highly expressed in chemo-sensitive tissues and predicted a better prognosis of TNBC. Functionally, ectopic expression of miR-770 suppressed the doxorubicin-resistance of TNBC cell lines via regulation of apoptosis and tumor microenvironment, which was mediated by exosomes. Moreover, miR-770 overexpression inhibited the migration and invasion. Rescue of STMN1 could partly reverse the effect of miR-770 in TNBC behaviors. Furthermore, we also demonstrated that overexpression of miR-770 inhibited DOX resistance and metastasis in vivo. Taken together, our results proved that miR-770 could suppress the doxorubicin-resistance and metastasis of TNBC cells, which broaden our insights into the underlying mechanisms in chemo-resistance and metastasis, and provided a new prognostic marker for TNBC cells.

Citing Articles

Potential biological roles of exosomal non-coding RNAs in breast cancer.

Li X, Gong J, Ni X, Yin J, Zhang Y, Lv Z FASEB J. 2025; 39(6):e70456.

PMID: 40079186 PMC: 11904755. DOI: 10.1096/fj.202500022R.

Role of Triple-Negative Breast Cancer-Derived Extracellular Vesicles in Metastasis: Implications for Therapeutics and Biomarker Development.

Wan X, Yang L, Wu L, Lei J, Li J J Cell Mol Med. 2025; 29(5):e70448.

PMID: 40032646 PMC: 11875785. DOI: 10.1111/jcmm.70448.

Exosomes-based liquid biopsy: An effective approach for drugs and therapeutics resistance screening in cancer.

Nyahatkar S, Kalele K J Liq Biopsy. 2025; 4:100144.

PMID: 40027144 PMC: 11863703. DOI: 10.1016/j.jlb.2024.100144.

Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance.

Zhang H, Wu B, Wang Y, Du H, Fang L Molecules. 2025; 30(3).

PMID: 39942602 PMC: 11819960. DOI: 10.3390/molecules30030498.

The role of exosomal non-coding RNAs in the breast cancer tumor microenvironment.

Saadh M, Allela O, Kareem R, Ballal S, Chahar M, Saini S Funct Integr Genomics. 2025; 25(1):32.

PMID: 39891771 DOI: 10.1007/s10142-025-01531-2.

References

Raiter A, Yerushalmi R, Hardy B . Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells. Oncotarget. 2014; 5(22):11452-63. PMC: 4294336. DOI: 10.18632/oncotarget.2576. View

Fischer K, Durrans A, Lee S, Sheng J, Li F, Wong S . Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015; 527(7579):472-6. PMC: 4662610. DOI: 10.1038/nature15748. View

Davuluri G, Schiemann W, Plow E, Sossey-Alaoui K . Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis. JAKSTAT. 2015; 3(4):e1009276. PMC: 4580088. DOI: 10.1080/21623996.2015.1009276. View

Isakoff S . Triple-negative breast cancer: role of specific chemotherapy agents. Cancer J. 2010; 16(1):53-61. PMC: 2882502. DOI: 10.1097/PPO.0b013e3181d24ff7. View

Zhao H, Yu X, Ding Y, Zhao J, Wang G, Wu X . MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. Oncotarget. 2016; 7(33):53254-53268. PMC: 5288183. DOI: 10.18632/oncotarget.10736. View

Niu M, Valdes S, Naguib Y, Hursting S, Cui Z . Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. Mol Pharm. 2016; 13(6):1833-42. PMC: 4899190. DOI: 10.1021/acs.molpharmaceut.5b00987. View

Li J, Liu S, Zhou H, Qu L, Yang J . starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013; 42(Database issue):D92-7. PMC: 3964941. DOI: 10.1093/nar/gkt1248. View

Zhou W, Fong M, Min Y, Somlo G, Liu L, Palomares M . Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014; 25(4):501-15. PMC: 4016197. DOI: 10.1016/j.ccr.2014.03.007. View

Niu J, Xue A, Chi Y, Xue J, Wang W, Zhao Z . Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer. Oncogene. 2015; 35(10):1302-1313. PMC: 4666837. DOI: 10.1038/onc.2015.189. View

10.

Wang J, Yao Y, Ming Y, Shen S, Wu N, Liu J . Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo. Sci Rep. 2016; 6:28833. PMC: 4923895. DOI: 10.1038/srep28833. View

11.

Anders C, Carey L . Understanding and treating triple-negative breast cancer. Oncology (Williston Park). 2008; 22(11):1233-9. PMC: 2868264. View

12.

Di Modica M, Regondi V, Sandri M, Iorio M, Zanetti A, Tagliabue E . Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers. Cancer Lett. 2016; 384:94-100. DOI: 10.1016/j.canlet.2016.09.013. View

13.

Zheng X, Carstens J, Kim J, Scheible M, Kaye J, Sugimoto H . Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015; 527(7579):525-530. PMC: 4849281. DOI: 10.1038/nature16064. View

14.

Carey L, Dees E, Sawyer L, Gatti L, Moore D, Collichio F . The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 2007; 13(8):2329-34. DOI: 10.1158/1078-0432.CCR-06-1109. View

15.

Nakasone E, Askautrud H, Kees T, Park J, Plaks V, Ewald A . Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell. 2012; 21(4):488-503. PMC: 3332002. DOI: 10.1016/j.ccr.2012.02.017. View

16.

Rider M, Hurwitz S, Meckes Jr D . ExtraPEG: A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles. Sci Rep. 2016; 6:23978. PMC: 4828635. DOI: 10.1038/srep23978. View

17.

Kuang X, Chen L, Zhang Z, Liu Y, Zheng Y, Ling H . Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients. Oncotarget. 2015; 6(26):22227-38. PMC: 4673159. DOI: 10.18632/oncotarget.4276. View

18.

Heckman K, Pease L . Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc. 2007; 2(4):924-32. DOI: 10.1038/nprot.2007.132. View

19.

Yao H, He G, Yan S, Chen C, Song L, Rosol T . Triple-negative breast cancer: is there a treatment on the horizon?. Oncotarget. 2016; 8(1):1913-1924. PMC: 5352107. DOI: 10.18632/oncotarget.12284. View

20.

Hsieh S, Huang S, Yu M, Yeh T, Chen T, Lin Y . Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog. 2010; 49(5):476-87. DOI: 10.1002/mc.20627. View